PL313116A1 - Application of n-alkalated 1,4-dihydropridinocarboxylic esters as drugs - Google Patents
Application of n-alkalated 1,4-dihydropridinocarboxylic esters as drugsInfo
- Publication number
- PL313116A1 PL313116A1 PL94313116A PL31311694A PL313116A1 PL 313116 A1 PL313116 A1 PL 313116A1 PL 94313116 A PL94313116 A PL 94313116A PL 31311694 A PL31311694 A PL 31311694A PL 313116 A1 PL313116 A1 PL 313116A1
- Authority
- PL
- Poland
- Prior art keywords
- dihydropridinocarboxylic
- alkalated
- drugs
- esters
- application
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4328884A DE4328884A1 (en) | 1993-08-27 | 1993-08-27 | Use of N-alkylated 1,4-dihydropyridinecarboxylic acid esters as medicaments |
PCT/EP1994/002723 WO1995005823A1 (en) | 1993-08-27 | 1994-08-16 | Use of n-alkylated 1,4-dihydropyridine dicarboxylic acid esters as medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
PL313116A1 true PL313116A1 (en) | 1996-06-10 |
Family
ID=6496196
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL94313116A PL313116A1 (en) | 1993-08-27 | 1994-08-16 | Application of n-alkalated 1,4-dihydropridinocarboxylic esters as drugs |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0714301A1 (en) |
JP (1) | JPH09501923A (en) |
KR (1) | KR960703594A (en) |
CN (1) | CN1129906A (en) |
AU (1) | AU7613594A (en) |
BG (1) | BG100367A (en) |
CA (1) | CA2170285A1 (en) |
CZ (1) | CZ43896A3 (en) |
DE (1) | DE4328884A1 (en) |
HU (1) | HUT75302A (en) |
NO (1) | NO960777L (en) |
PL (1) | PL313116A1 (en) |
WO (1) | WO1995005823A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19741694C2 (en) * | 1997-09-18 | 2002-10-31 | Schering Ag | Use of complexes whose ligand is a bis-amine oxime derivative or an N¶2¶S¶2¶ derivative and whose central atom is a radionuclide |
CA2470813A1 (en) * | 2001-12-20 | 2003-07-03 | Bayer Healthcare Ag | 1,4-dihydro-1,4-diphenylpyridine derivatives |
CN110606822A (en) * | 2011-11-24 | 2019-12-24 | 里克特吉迪翁公司 | 1,4-dihydropyridine derivatives having HSP modulating activity |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3222367A1 (en) * | 1982-06-15 | 1983-12-15 | Bayer Ag, 5090 Leverkusen | Use of 1,4-dihydropyridines in antiarteriosclerotics and preparation thereof |
EP0169009A3 (en) * | 1984-07-17 | 1988-08-31 | FISONS plc | Novel dihydropyridine derivatives and their production, formulation and use as pharmaceuticals |
DE4011695A1 (en) * | 1990-04-11 | 1991-10-17 | Bayer Ag | USE OF N-ALKYLATED 1,4-DIHYDROPYRIDE INDICARBOXIC ACID ESTERS AS DRUGS, NEW COMPOUNDS AND METHOD FOR THEIR PREPARATION |
-
1993
- 1993-08-27 DE DE4328884A patent/DE4328884A1/en not_active Withdrawn
-
1994
- 1994-08-16 JP JP7507325A patent/JPH09501923A/en not_active Ceased
- 1994-08-16 AU AU76135/94A patent/AU7613594A/en not_active Abandoned
- 1994-08-16 EP EP94926199A patent/EP0714301A1/en not_active Withdrawn
- 1994-08-16 CA CA002170285A patent/CA2170285A1/en not_active Abandoned
- 1994-08-16 WO PCT/EP1994/002723 patent/WO1995005823A1/en not_active Application Discontinuation
- 1994-08-16 KR KR1019960700944A patent/KR960703594A/en not_active Application Discontinuation
- 1994-08-16 CZ CZ96438A patent/CZ43896A3/en unknown
- 1994-08-16 CN CN94193170A patent/CN1129906A/en active Pending
- 1994-08-16 PL PL94313116A patent/PL313116A1/en unknown
- 1994-08-16 HU HU9600472A patent/HUT75302A/en unknown
-
1996
- 1996-02-19 BG BG100367A patent/BG100367A/en unknown
- 1996-02-26 NO NO960777A patent/NO960777L/en unknown
Also Published As
Publication number | Publication date |
---|---|
BG100367A (en) | 1996-07-31 |
NO960777L (en) | 1996-04-10 |
EP0714301A1 (en) | 1996-06-05 |
DE4328884A1 (en) | 1995-03-02 |
CA2170285A1 (en) | 1995-03-02 |
CZ43896A3 (en) | 1996-05-15 |
AU7613594A (en) | 1995-03-21 |
HUT75302A (en) | 1997-05-28 |
NO960777D0 (en) | 1996-02-26 |
KR960703594A (en) | 1996-08-31 |
JPH09501923A (en) | 1997-02-25 |
WO1995005823A1 (en) | 1995-03-02 |
HU9600472D0 (en) | 1996-04-29 |
CN1129906A (en) | 1996-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU9402974D0 (en) | Pharmaceutical composition | |
AU3888793A (en) | Novel medicament | |
ZA946262B (en) | Pharmaceutical compositions | |
AU3720193A (en) | Hydroisoindolines and hydroisoquinolines as psychotropic drugs | |
ZA945930B (en) | Pharmaceutical composition | |
GB9317610D0 (en) | Pharmaceutical compositions | |
AU1282395A (en) | Novel benzamide derivative and medicinal composition containing the same | |
GB9303538D0 (en) | Medicament presentation | |
PL314036A1 (en) | Pharmaceutical composition | |
GB9303525D0 (en) | Medicament presentation | |
CA2100836A1 (en) | Pharmaceutical Composition | |
GB9317504D0 (en) | Pharmaceutical compositions | |
ZA945752B (en) | Pharmaceutical composition | |
PL313116A1 (en) | Application of n-alkalated 1,4-dihydropridinocarboxylic esters as drugs | |
PL310146A1 (en) | Application of 1,4-dihydropyridino-3,5-dicarboxylic esters as drugs as well as novel active substances and drugs | |
GB9318880D0 (en) | Pharmaceutical composition | |
AU7318994A (en) | Thf-gamma2 analogs and pharmaceutical compositions comprising them | |
HU9401771D0 (en) | Pharmaceutical compositions cintaining ipsapiron | |
AU3528593A (en) | Pharmaceutical composition | |
GB9420129D0 (en) | Pharmaceutical compositions | |
AU5239493A (en) | Methods for administration of taxol | |
ZA935269B (en) | Pharmaceutical composition | |
GB9320688D0 (en) | Pharmaceutical composition | |
GB9318350D0 (en) | Pharmaceutical composition | |
HU9303386D0 (en) | Pharmaceutical composition |